Filing metadata

Accession number
0000921895-21-001334
Form type
Form 4
Filer
Summit Therapeutics Inc.
CIK
CIK 1599298
Filed
May 14, 2021
Reporting period
May 12, 2021
Description
Insider transaction

Explore SEC Filings Hub